Responses
Other responses
Jump to comment:
- Published on: 18 April 2016
- Published on: 18 April 2016
- Published on: 18 April 2016Response to Dr A R Weale et alShow More
Dear Editor
the critical letter of Drs Weale and Rees merits some comments:
Multicenter clinical studies on probiotics are just starting up. As is normal practise, they have been preceded by some pilot studies. It is obvious that before investing a large amount of money in a multicenter study, pharmaceutical companies need to know that the effectiveness of the drug under examination is supported by bo...
Conflict of Interest:
None declared. - Published on: 18 April 2016Repeating the same mistakes as other studiesShow More
Dear Editor
We read the study by Prantera and colleagues, with great interest. As the authors assert, there have been few good quality and well designed clinical trials, with sufficient power, to examine the effects of probiotics on inflammatory bowel disease.
This trial unfortunately also has a number of weaknesses both in its reporting and methodology.
The report does not make clear the exact...
Conflict of Interest:
None declared.